Sign in

CIK 0001906324

  • Large accelerated filer

QuidelOrtho Corp

Sign in to watch
Ticker
QDEL
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Jan 1
Entity type
Operating
EIN
874496285
Phone
+1 858-552-1100
Business address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
Former names
Coronado Topco, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-31 Hodges Michelle A. SVP, General Counsel Grant or award +1,020 11,763
2024-01-31 Hodges Michelle A. SVP, General Counsel Shares withheld for taxes −340 $68.51 $23K 11,423
2024-01-31 Hodges Michelle A. SVP, General Counsel Grant or award +204 11,627
2024-01-31 Hodges Michelle A. SVP, General Counsel Shares withheld for taxes −73 $68.51 $5K 11,554
2024-01-31 Hodges Michelle A. SVP, General Counsel Exercise or conversion · Restricted Stock Units −1,610 3,220
2024-01-31 Hodges Michelle A. SVP, General Counsel Exercise or conversion · Restricted Stock Units −3,628 3,628
2024-01-31 Hodges Michelle A. SVP, General Counsel Exercise or conversion · Restricted Stock Units (Converted) −1,020 0
2024-01-31 Hodges Michelle A. SVP, General Counsel Exercise or conversion · Restricted Stock Units (Premium ) −204 0
2024-01-31 Kroll Werner SVP, Research & Development Grant or award +3,628 33,343
2024-01-31 Kroll Werner SVP, Research & Development Shares withheld for taxes −1,946 $68.51 $133K 31,397
2024-01-31 Kroll Werner SVP, Research & Development Grant or award +3,547 34,944
2024-01-31 Kroll Werner SVP, Research & Development Shares withheld for taxes −1,806 $68.51 $124K 33,138
2024-01-31 Kroll Werner SVP, Research & Development Exercise or conversion · Restricted Stock Units −3,628 3,628
2024-01-31 Kroll Werner SVP, Research & Development Exercise or conversion · Restricted Stock Units −3,547 3,548
2024-01-31 Bujarski Robert Joseph EVP & COO Grant or award +3,219 39,685
2024-01-31 Bujarski Robert Joseph EVP & COO Shares withheld for taxes −1,924 $68.51 $132K 37,761
2024-01-31 Bujarski Robert Joseph EVP & COO Grant or award +6,772 44,533
2024-01-31 Bujarski Robert Joseph EVP & COO Shares withheld for taxes −3,857 $68.51 $264K 40,676
2024-01-31 Bujarski Robert Joseph EVP & COO Exercise or conversion · Restricted Stock Units −3,219 6,440
2024-01-31 Bujarski Robert Joseph EVP & COO Exercise or conversion · Restricted Stock Units −6,772 6,773

Page 30 of 33 · 642 trades